Financial & Business News
LATEST INVESTING HEADLINES
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Acadia Healthcare To Contact Him Directly To Discuss Their Options
Destination XL Group, Inc. (NASDAQ:DXLG ) Q3 2024 Earnings Conference Call November 22, 2024 9:00 AM ET Company Participants Shelly Mokas - Vice President of Financial Reporting and SEC Compliance Harvey Kanter - President, Chief Executive Officer and Director Peter Stratton - Executive Vice President, Chief Financial Officer and Treasurer Conference Call Participants Michael Baker - D.A. Davidson Operator Good day, everyone, and welcome to the Destination XL Group Third Quarter Fiscal 2024 Financial Results Conference Call.
Amazon.com Inc (NASDAQ:AMZN) is putting another $4 billion into artificial intelligence startup Anthropic, it said on Friday, following a similar $4 billion investment earlier this year. As part of the previous agreement, Anthropic committed to using Amazon Web Services (AWS) data centers and incorporating AWS-designed AI chips into its operations.
ATUS plans to bring 100% fiber broadband to more than two-thirds of its footprint over the next few years.
IDEXX's robust strength in the CAG Diagnostics business and strong global performance are highly promising.
SNEX, MNDY and NCLH made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on November 22, 2024.
Insulet's Omnipod 5 System is now compatible with Abbott's FreeStyle Libre 2 Plus Sensor in the United States.
The performance of a few stocks over the last few months has left a sour taste in investors' mouths, with popular stocks such as NIKE NKE and Super Micro Computer SMCI unable to gain any meaningful traction.
NEW YORK, NY / ACCESSWIRE / November 22, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=113136&wire=1 or contact Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / November 22, 2024 / If you suffered a loss on your Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/evolv-technologies-holdings-inc-lawsuit-submission-form-2?prid=113129&wire=1 or contact Joseph E. Levi, Esq.